Kestra Advisory Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Sell |
10,324
-344
| -3% | -$10.3K | ﹤0.01% | 2312 |
|
|
2025
Q1 | $304K | Sell |
10,668
-656
| -6% | -$18.7K | ﹤0.01% | 2163 |
|
|
2024
Q4 | $374K | Buy |
11,324
+3
| +0% | +$99 | ﹤0.01% | 2064 |
|
|
2024
Q3 | $423K | Sell |
11,321
-40
| -0.4% | -$1.49K | ﹤0.01% | 1865 |
|
|
2024
Q2 | $382K | Sell |
11,361
-2,663
| -19% | -$89.4K | ﹤0.01% | 1958 |
|
|
2024
Q1 | $501K | Sell |
14,024
-662
| -5% | -$23.7K | ﹤0.01% | 1666 |
|
|
2023
Q4 | $484K | Buy |
14,686
+500
| +4% | +$16.5K | ﹤0.01% | 1554 |
|
|
2023
Q3 | $386K | Buy |
14,186
+1,979
| +16% | +$53.9K | ﹤0.01% | 1509 |
|
|
2023
Q2 | $385K | Hold |
12,207
| – | – | ﹤0.01% | 1452 |
|
|
2023
Q1 | $332K | Hold |
12,207
| – | – | ﹤0.01% | 1506 |
|
|
2022
Q4 | $371K | Sell |
12,207
-1,232
| -9% | -$37.4K | ﹤0.01% | 1592 |
|
|
2022
Q3 | $405K | Buy |
13,439
+985
| +8% | +$29.7K | ﹤0.01% | 1432 |
|
|
2022
Q2 | $345K | Buy |
12,454
+79
| +0.6% | +$2.19K | ﹤0.01% | 1539 |
|
|
2022
Q1 | $416K | Sell |
12,375
-100
| -0.8% | -$3.36K | ﹤0.01% | 1396 |
|
|
2021
Q4 | $527K | Buy |
12,475
+100
| +0.8% | +$4.22K | 0.01% | 1289 |
|
|
2021
Q3 | $563K | Hold |
12,375
| – | – | 0.01% | 1323 |
|
|
2021
Q2 | $605K | Hold |
12,375
| – | – | 0.01% | 1189 |
|
|
2021
Q1 | $622K | Sell |
12,375
-3,074
| -20% | -$155K | 0.01% | 1092 |
|
|
2020
Q4 | $812K | Buy |
15,449
+2,518
| +19% | +$132K | 0.01% | 964 |
|
|
2020
Q3 | $532K | Buy |
+12,931
| New | +$532K | 0.01% | 856 |
|